Suchergebnisse - "DeYoung, Mary Beth"

PubPharm (20)

1

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine : achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

2

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

3

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

4

Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors : meta-analysis and systematic review

enthalten in: Clinical therapeutics | 2012

von Aroda, V. | Henry, R. | Han, J. | +4

ErratumIn: Clin Ther. 2014 Feb 1;36(2):307-8

5

Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review

enthalten in: Clinical therapeutics | 2012

von Aroda, V. | Henry, R. | Han, J. | +4

6

Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States

enthalten in: Journal of medical economics | 2012

von Guillermin, A. | Lloyd, A. | Best, J. | +3

7

Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes

enthalten in: Diabetes technology & therapeutics | 2011

von DeYoung, M. | MacConell, L. | Sarin, V. | +2

8

Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes

enthalten in: Diabetes technology & therapeutics | 2011

von DeYoung, M. | MacConell, L. | Sarin, V. | +2

9

Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes

enthalten in: Postgraduate medicine | 2011

von Aroda, V. | DeYoung, M.

10

Dose accuracy and injection force of disposable pens delivering pramlintide for the treatment of diabetes

enthalten in: Journal of diabetes science and technology | 2010

von Merritt, D. | Schreiner, B. | Harris, S. | +3